leucine and Granulocytic Leukemia, Chronic

leucine has been researched along with Granulocytic Leukemia, Chronic in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (12.50)	18.7374
1990's	7 (43.75)	18.2507
2000's	5 (31.25)	29.6817
2010's	2 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Divoka, M; Divoky, V; Faber, E; Indrak, K; Jarosova, M; Mojzikova, R; Plachy, R; Rozmanova, S; Stastny, M	1
Bassan, R; Bussini, A; Castagnetti, F; Gnani, A; Intermesoli, T; Rosti, G; Soverini, S; Spinelli, O	1
Abe, F; Fujisaki, T; Gondo, H; Niho, Y; Ohhinata, A; Okamura, T; Otsuka, T	1
AGOSTONI, A; DIOGUARDI, N; FIORELLI, G; IDEO, G; TITTOBELLO, A	1
GAVOSTO, F; MARAINI, G; PILERI, A	1
Griffin, JD; Ikeda, Y; Kizaki, M; Miyakawa, Y; Sawafuji, K; Weisberg, E	1
Fujimaki, K; Ishigatsubo, Y; Kanamori, H; Koharazawa, H; Taguchi, J; Takabayashi, M; Takasaki, H; Yamaji, S	1
Irvine, AE; Lynas, J; Magill, L; Morris, TC; Walker, B	1
Baccarani, M; Bosi, C; Castagnetti, F; Cilloni, D; Colarossi, S; Giannoulia, P; Gnani, A; Iacobucci, I; Luatti, S; Martinelli, G; Marzocchi, G; Palandri, F; Paolini, S; Piccaluga, PP; Rondoni, M; Rosti, G; Saglio, G; Soverini, S; Testoni, N	1
Abe, F; Fujii, H; Sukenaga, Y; Takeuchi, T; Yamada, M	1
Saito, Y; Uzuka, Y	2
Hiraoka, A; Masaoka, T; Shibata, H	1
Catovsky, D; Gill, R; Levi, S; Marshall, CJ; Matutes, E; Urbano-Ispizua, A; Wiedemann, LM	1
Saito, Y; Usuka, Y	1
Im, T; Nakao, H; Oohira, H; Ota, K; Sannomiya, Y; Sasaki, A; Tatsumi, N; Yasui, Y	1

Trials

1 trial(s) available for leucine and Granulocytic Leukemia, Chronic

Article	Year
Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT. Transplantation proceedings, 1992, Volume: 24, Issue:6 Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Infant; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Recurrence	1992

Article

Year

Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.

Transplantation proceedings, 1992, Volume: 24, Issue:6

Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Infant; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Recurrence

1992

Other Studies

15 other study(ies) available for leucine and Granulocytic Leukemia, Chronic

Article	Year
Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation. Leukemia research, 2010, Volume: 34, Issue:4 Topics: Amino Acid Substitution; Antineoplastic Agents; Cytogenetic Analysis; Dasatinib; Drug Resistance, Neoplasm; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Phenylalanine; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcr; Pyrimidines; Thiazoles; Treatment Outcome	2010
Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib. Leukemia research, 2012, Volume: 36, Issue:1 Topics: Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Pharmacological; Biomarkers, Tumor; Dasatinib; Female; Fusion Proteins, bcr-abl; Glutamic Acid; Humans; Imatinib Mesylate; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Mutation, Missense; Phenylalanine; Piperazines; Polymorphism, Single Nucleotide; Pyrimidines; Remission Induction; Thiazoles; Time Factors; Treatment Outcome	2012
Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia. International immunopharmacology, 2003, Volume: 3, Issue:6 Topics: Cell Count; Cells, Cultured; Clone Cells; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukotriene C4; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stem Cells	2003
CHROMATOGRAPHIC STUDIES ON LEUCINE AMINOPEPTIDASE IN NORMAL HUMAN GRANULOCYTES AND IN CELLS OF ACUTE AND CHRONIC MYELOID LEUKEMIA. Enzymologia biologica et clinica, 1963, Volume: 79 Topics: Aminopeptidases; Blood Chemical Analysis; Chromatography; Granulocytes; Humans; Leucine; Leucyl Aminopeptidase; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes	1963
[Incorporation of tritium-labeled DL-leucine into the blood cells in acute leukosis and in chronic myeloid leukemia]. Bollettino della Societa italiana di biologia sperimentale, 1960, Mar-15, Volume: 36 Topics: Blood Cells; Humans; Leucine; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Tritium	1960
Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways. Leukemia & lymphoma, 2003, Volume: 44, Issue:11 Topics: Aminopeptidases; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Caspases; Cell Division; Cyclin D1; Drug Resistance, Neoplasm; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hydroxamic Acids; Imatinib Mesylate; K562 Cells; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Protease Inhibitors; Pyrimidines; Serine; Signal Transduction	2003
Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia. Anti-cancer drugs, 2004, Volume: 15, Issue:7 Topics: Aged; Bone Marrow Cells; Busulfan; Humans; Immunologic Factors; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Philadelphia Chromosome; Remission Induction; Time Factors	2004
Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myeloma. Haematologica, 2004, Volume: 89, Issue:12 Topics: Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Edetic Acid; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; HL-60 Cells; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; Neoplasm Proteins; Pepstatins; Protease Inhibitors; Proteasome Endopeptidase Complex; Recombinant Fusion Proteins; Sulfones; Transfection	2004
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-20, Volume: 24, Issue:33 Topics: Adult; Antineoplastic Agents; Blast Crisis; Clinical Trials, Phase II as Topic; Dasatinib; Disease Progression; Drug Resistance, Neoplasm; Female; Genes, abl; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mutation; Phenylalanine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Failure	2006
Purification and characterization of a ubenimex (Bestatin)-sensitive aminopeptidase B-like enzyme from K562 human chronic myeloid leukemia cells. FEBS letters, 1994, Mar-28, Volume: 342, Issue:1 Topics: Amino Acid Sequence; Aminopeptidases; Cations, Divalent; Chlorides; Humans; Hydrogen-Ion Concentration; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Sequence Data; Molecular Weight; Substrate Specificity; Tumor Cells, Cultured	1994
[Bestatin therapy of chronic myelogenous leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Remission Induction; Survival Rate	1993
Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case. Leukemia, 1992, Volume: 6, Issue:4 Topics: Codon; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Genes, ras; Glutamine; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Mutation; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transcriptional Activation	1992
Bestatin treatment of myelodysplastic syndromes and chronic myelogenous leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1991, Volume: 45, Issue:2-3 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Busulfan; Drug Therapy, Combination; Female; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes	1991
Effects of ubenimex, a biological response modifier, on myelodysplastic syndrome and chronic leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1991, Volume: 45, Issue:2-3 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Humans; Immunologic Factors; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes	1991
[Combination therapy of chronic myelogenous leukemia with busulfan and bestatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Gene Rearrangement; Humans; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Remission Induction	1991